High Tower Advisors, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.17 - $5.31 $0 - $26	5 Added 0.03%	15,089 $2,000
Q2 2022 Aug 10, 2022	SELL	$0.21 - $0.53 $187 - $473	-893 Reduced 5.59%	15,084 $4,000
Q4 2021 Feb 10, 2022	BUY	$0.6 - $1.11 $180 - $333	300 Added 1.91%	15,977 $9,000
Q3 2021 Nov 12, 2021	SELL	$1.01 - $1.82 $143 - $258	-142 Reduced 0.9%	15,677 $16,000
Q1 2021 May 10, 2021	BUY	$1.27 - $3.42 $63 - $171	50 Added 0.32%	15,819 $31,000
Q4 2020 Feb 10, 2021	BUY	$0.94 - $1.89 $14,822 - $29,803	15,769 New	15,769 $21,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.